1pxx: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /><applet load="1pxx" size="450" color="white" frame="true" align="right" spinBox="true" caption="1pxx, resolution 2.90Å" /> '''CRYSTAL STRUCTURE OF... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1pxx.gif|left|200px]]<br /><applet load="1pxx" size=" | [[Image:1pxx.gif|left|200px]]<br /><applet load="1pxx" size="350" color="white" frame="true" align="right" spinBox="true" | ||
caption="1pxx, resolution 2.90Å" /> | caption="1pxx, resolution 2.90Å" /> | ||
'''CRYSTAL STRUCTURE OF DICLOFENAC BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2'''<br /> | '''CRYSTAL STRUCTURE OF DICLOFENAC BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2'''<br /> | ||
==Overview== | ==Overview== | ||
A variety of drugs inhibit the conversion of arachidonic acid to | A variety of drugs inhibit the conversion of arachidonic acid to prostaglandin G2 by the cyclooxygenase (COX) activity of prostaglandin endoperoxide synthases. Several modes of inhibitor binding in the COX active site have been described including ion pairing of carboxylic acid containing inhibitors with Arg-120 of COX-1 and COX-2 and insertion of arylsulfonamides and sulfones into the COX-2 side pocket. Recent crystallographic evidence suggests that Tyr-385 and Ser-530 chelate polar or negatively charged groups in arachidonic acid and aspirin. We tested the generality of this binding mode by analyzing the action of a series of COX inhibitors against site-directed mutants of COX-2 bearing changes in Arg-120, Tyr-355, Tyr-348, and Ser-530. Interestingly, diclofenac inhibition was unaffected by the mutation of Arg-120 to alanine but was dramatically attenuated by the S530A mutation. Determination of the crystal structure of a complex of diclofenac with murine COX-2 demonstrates that diclofenac binds to COX-2 in an inverted conformation with its carboxylate group hydrogen-bonded to Tyr-385 and Ser-530. This finding represents the first experimental demonstration that the carboxylate group of an acidic non-steroidal anti-inflammatory drug can bind to a COX enzyme in an orientation that precludes the formation of a salt bridge with Arg-120. Mutagenesis experiments suggest Ser-530 is also important in time-dependent inhibition by nimesulide and piroxicam. | ||
==About this Structure== | ==About this Structure== | ||
1PXX is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with NAG, BOG, HEM and DIF as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Prostaglandin-endoperoxide_synthase Prostaglandin-endoperoxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.99.1 1.14.99.1] Full crystallographic information is available from [http:// | 1PXX is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=NAG:'>NAG</scene>, <scene name='pdbligand=BOG:'>BOG</scene>, <scene name='pdbligand=HEM:'>HEM</scene> and <scene name='pdbligand=DIF:'>DIF</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Prostaglandin-endoperoxide_synthase Prostaglandin-endoperoxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.99.1 1.14.99.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1PXX OCA]. | ||
==Reference== | ==Reference== | ||
| Line 14: | Line 14: | ||
[[Category: Prostaglandin-endoperoxide synthase]] | [[Category: Prostaglandin-endoperoxide synthase]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Kalgutkar, A | [[Category: Kalgutkar, A S.]] | ||
[[Category: Kiefer, J | [[Category: Kiefer, J R.]] | ||
[[Category: Kozak, K | [[Category: Kozak, K R.]] | ||
[[Category: Kurumbail, R | [[Category: Kurumbail, R G.]] | ||
[[Category: Marnett, L | [[Category: Marnett, L J.]] | ||
[[Category: Pawlitz, J | [[Category: Pawlitz, J L.]] | ||
[[Category: Prusakiewicz, J | [[Category: Prusakiewicz, J J.]] | ||
[[Category: Rowlinson, S | [[Category: Rowlinson, S W.]] | ||
[[Category: Stallings, W | [[Category: Stallings, W C.]] | ||
[[Category: BOG]] | [[Category: BOG]] | ||
[[Category: DIF]] | [[Category: DIF]] | ||
| Line 34: | Line 34: | ||
[[Category: prostaglandin]] | [[Category: prostaglandin]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:33:41 2008'' | ||